本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Carisma Therapeutics

0.2497
+0.047823.68%
盘后0.2493-0.0004-0.16%19:54 EDT
成交量:124.04万
成交额:28.81万
市值:1,043.45万
市盈率:-0.17
高:0.2637
开:0.2090
低:0.2030
收:0.2019
数据加载中...
2024/05/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

重要事件披露

Form 8-K - Current report
2024/04/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]